Biogen Medical Research
Multiple Sclerosis
Scientific Objectives
We are currently only accepting proposals from the United States.
The following areas of research are currently being considered:
- General MS
- MS and its treatment in special populations, i.e. older or pediatric patients, family planning, LGBTQ+ patients, underrepresented populations
- Diroximel Fumarate
- Comparative effectiveness as assessed by PROs, quality of life, treatment satisfaction and/or adherence vs newer DMTs in the treatment of naïve and/or switch patients
- Natalizumab
- Examination of long-term outcomes
Research support is awarded on a highly competitive basis, and submission of research proposals in these areas of interest does not guarantee support will be awarded.